CB1-IN-1 Catalog No.:M21313-C but has minimal effect on

but has minimal effect on viability of nontransformed human cells

Chemical Name: 5-Bromo-2-methoxy-N-(6-methoxy-3-methylbenzo[d]-isoxazol-5-yl)benzenesulfonamide

Smiles: NCCOCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O

Smiles: CC(=O)OC(C)(C)C=CC(=O)C(C)(O)C1C(O)CC2(C)C3CC=C4C(C=C(O)C(=O)C4(C)C)C3(C)C(=O)CC21C

CB1-IN-1 Catalog No.:M21313-C but has minimal effect onCB1 IN 1 (BPRCB1184) is a peripherally restricted CB1R antagonist, with Ki of 0. 3 nM and 21 nM for CB1R (EC50 = 3 nM) and CB2R, respectively. IC50 value: 0. 3 nM (Ki, CB1R) 21 nM (Ki, CB2R)Target: CB1Rin vivo: CB1 IN 1 is a novel peripherally restricted cannabinoid 1 receptor antagonist with significant weight loss efficacy in diet induced obese mice. CB1 IN 1 has great potential to ameliorate this related metabolic syndrome. Product information CAS